CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Intracellular glutathione content in leukemias
Authors
Burgut R.
Paydas S.
+3 more
Sahin B.
Seyrek E.
Yuregir G.T.
Publication date
1 January 1995
Publisher
'S. Karger AG'
Doi
Cite
Abstract
PubMedID: 7854769The intracellular glutathione (GSH) content was measured in 73 patients with leukemia and compared with controls. GSH content was between 1.16 and 5.55 µmol/g protein (mean 2.96 ± 0.86) in the study group and between 0.5 and 1.48 µmol/g protein (mean 1.31 ± 0.27) in the control group, statistically significant difference (p = 0.0000). There was no significant difference between acute and chronic leukemias, lymphoid and myeloid leukemias and, more importantly, newly diagnosed and relapsed patients. GSH content did not change significantly with clinical and hematologic parameters such as age, sex, and initial hematologic findings. In addition, variable changes were detected over 24 h in 9 patients. It can be concluded that GSH content in leukemic cells was higher than in controls and showed a wide range. The absence of a relationship between GSH content and clinical and laboratory parameters suggested that GSH is not the sole determinant of response to cytotoxic drugs. GSH variation over a 24-hour period may be important in the timing and success of chemotherapy for leukemias. © 1995 S. Karger AG, Basel
Similar works
Full text
Available Versions
Çukurova University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:openaccess.cu.edu.tr:20.50...
Last time updated on 06/02/2020